CryoPort Inc (CYRX)

[robertmaxwell]

Cold,

Re-reading my most recent post, I apologize if I was abrasive. Certainly wasn't the intention. Of course, given my history of "coming in hot," I should've been more mindful.

To your questions awhile back - while I don't remember each question word-for-word, I do recall reading them and thinking that a few were going to be off-limits at the time. However, we're all, in effect, on the same team here. I'd like to be as helpful as possible to you all, unfortunately right now I don't have time to come here each day and actively participate in the discourse.

Quickly - good eye on Roth's initiating coverage. I'll point out to you that Richard Baldry, Roth's analyst on CYRX, isn't even on Roth's healthcare research team. In fact, he's the sole software analyst on their technology & media team. Hmmm...

Regarding my comment about Cryoport becoming interesting again at a six handle or upon new material developments: I still stand by that statement. Is it that simple? Of course not; it's never that simple. However, put concisely, that's the best way to summarize the most likely catalyst for renewed institutional interest.

Hope that's helpful for now. Feel free to ping me with other questions or to tell me if I've totally missed the ball here. I'm writing this as I'm about to crash from going on four days with ~18 hours combined sleep.